CVE Intelligence
High

CVE-2026-9509 — Uncaught exception vulnerability in Suprema's BioStar

An unhandled exception in Suprema BioStar 2 (Server), versions 2.9.8, 2.9.10, and 2.9.11, that allows an unauthenticated remote attacker to cause a denial of service (DoS) by sending HTTP POST requests to the ‘/api/migration’ endpoint. This request triggers a failure that halts critical processes, leaving the system offline until the services or server are manually restarted. As a result, access control readers cease to function, and potential failures may occur in third-party integrations. Since the exploit requires no privileges or user interaction and is trivial to automate, the impact on availability is high, and the effect extends to interconnected systems.

Published May 29, 2026 · Updated Oct 13, 2026 · Sources: NIST National Vulnerability Database, CVE Program (cve.org) e CISA ADP · CNA: INCIBE

Who exploits it and how urgent it is

A 0–100 score combining confirmed exploitation, ransomware and APT use, public exploits, EPSS and severity.

No exploitation signal in the sources consulted so far.
How the score was calculated
  • EPSS 0.5% (30-day exploitation probability)+7
  • Technical severity (high)+6
  • Automatable exploitation (SSVC)+3

The score orders the patch queue; it does not replace your asset context (internet exposure, criticality, compensating controls).

Triage

Is it exploited, how likely is exploitation, what does it touch, and how severe do the sources call it.

Exploitation
Not confirmed
Not in CISA KEV — an absence of record, not proof it is unexploited.
EPSS FIRST
0.54%
ahead of 44% of scored CVEs · Oct 14, 2026
Affects
Suprema
BioStar 2 (server)
CVSS base
8.7
High · 2 source(s)

CISA SSVC assessment CISA

Three decision points CISA publishes for the CVEs it assesses (SSVC 2.0.3). A stakeholder decision, not a severity score.

Exploitation
None
none · proof-of-concept · active
Automatable
Yes
can an attacker script the kill-chain steps
Technical impact
Partial
partial · total control of the vulnerable component

Remediation

Fixes and mitigations documented by the sources — linked to the original advisory.

No fix documented by the sources we poll. That does not mean none exists: check the vendor advisory.

First 24 hours

Ordered from the record’s own fields — exposure first, because you cannot patch what you have not found. A rule-generated starting point.

  1. Identify exposed assets running the affected vendor/product/version combinations (Suprema BioStar 2 (server)).
  2. The attack is network-based and needs no privileges: restrict exposure (ACLs, VPN, WAF) until patched.
  3. No fix documented in the sources: reduce exposure and monitor the vendor advisory.
  4. Search available logs for exploit probes, errors and authentication anomalies.

Affected scope

Vendor, product and versions as the sources word them.

VendorProductVersionsStatusSource
Suprema BioStar 2 (server) version v2.9.11version v2.9.10version v2.9.8 Vulnerable CVE Program (cve.org) e CISA ADP

Attack characteristics

The CVSS vector, decoded. It describes the attack, not your exposure to it.

Attack vector
Network
Attack complexity
Low
Attack requirements
None
Privileges required
None
User interaction
None
Scope
X
Confidentiality (vulnerable system)
None
Integrity (vulnerable system)
None
Availability (vulnerable system)
High
Confidentiality (subsequent)
None
Integrity (subsequent)
None
Availability (subsequent)
None

Every base score collected

Sources score independently and may disagree; each row says who scored it and under which version.

ScoreVersionSeverityExpl.ImpactScored by
8.7 CVSS 4.0 High — — cve-coordination@incibe.es via NIST National Vulnerability Database
8.7 CVSS 4.0 High — — INCIBE via CVE Program (cve.org) e CISA ADP
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X (score shown at the top: cve-coordination@incibe.es)

Weakness MITRE

Weakness class according to MITRE’s CWE catalog.

CWE-248

Other CVEs with this weakness →

EPSS over time FIRST

Oct 13, 2026 → Oct 14, 2026 · 2 reading(s) · max 0.54%

Detection

Read off the CVSS vector and the weakness class. Starting points, not tested rules.

  • Prioritize edge telemetry for the network-reachable component (proxy, WAF, IDS/IPS).
web/proxy/WAF logsnetwork IDS/IPS

Timeline

What happened to this CVE, newest first.

  • 2026
  • Affected products added · suprema/biostar 2 (server)
    Oct 13, 2026 · CVE Program (cve.org) e CISA ADP
  • SSVC assessment updated
    Oct 13, 2026 · CVE Program (cve.org) e CISA ADP
  • Record published
    Oct 13, 2026
  • CVSS changed · 8.7
    Oct 13, 2026 · NIST National Vulnerability Database
  • Source status changed · → Deferred
    Oct 13, 2026 · NIST National Vulnerability Database
  • Record created in this database
    Oct 13, 2026 · NIST National Vulnerability Database
  • CVE published
    May 29, 2026 · INCIBE

Source activity

Repeated readings are counted rather than listed.

  • 1× Official description updated · Oct 13, 2026 – Oct 13, 2026

References

1 on the record

Elsewhere on this site

Suprema
every CVE for this vendor
CWE-248
other pages naming this weakness

Related CVEs (same products)

  • CVE-2026-9508 Incorrect Permission Assignment for Critical Resource vulnerability in Suprema's BioStar May 29, 2026

Not in any source we poll

Listed rather than left blank: an empty field and an unmeasured one look identical on screen, and only one is a reason to look elsewhere.

  • No fixed version, patch or mitigation documented.
  • No confirmed IOCs, IP addresses, domains, file hashes, or malware artifacts supplied.
  • No organization-specific asset inventory, compensating-control status, or patch deployment evidence supplied.
  • No exploit packet captures, log samples, or incident case IDs supplied.

Answered from this record

Text assembled only from the fields above — no additional claims.

What should defenders know first?

CVE-2026-9509 is "Uncaught exception vulnerability in Suprema's BioStar", rated High. It affects BioStar 2 (server) (Suprema); versions are in the scope table. It is not in CISA KEV, which does not rule out exploitation. CVSS 8.7 describes technical severity. EPSS 0.54% estimates the probability of exploitation in 30 days; neither replaces your asset context. First verify whether exposed or business-critical assets run the affected versions, apply vendor fixes or mitigations, and preserve logs for review.

Comments

Moderated technical discussion. Read the community guidelines.

No comments yet.

Sign in or create an account to comment and suggest corrections.